Evidence map›Paper›PMID 17012032›Full record

ReviewMethods (San Diego, Calif.)2006

Use of analogs and inhibitors to study the functional significance of protein palmitoylation.

Marilyn D Resh

Open access · greenAbstract readReview
In one paragraph

Review in Methods (San Diego, Calif.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 157 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Palmitoylation of solute carriers.Biochemical pharmacology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Palmitoylation of Voltage-Gated Ion Channels.International journal of molecular sciences · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Inhibitors of DHHC family proteins.Current opinion in chemical biology · 2021
    Review
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Marilyn D ReshCell Biology Program, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 143, New York, NY 10021, USA. m-resh@ski.mskcc.org
Memorial Sloan Kettering Cancer Center · US

Funding

Palmitoylation of Hedgehog ProteinsR01GM057966 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI RESH, MARILYN D · 1998 to 2011
$3.2M
STRUCTURE AND FUNCTION OF HIV GAG PROTEINR01CA072309 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI RESH, MARILYN D · 1996 to 2009
$2.7M
NCI NIH HHS CA72309NCI NIH HHS R01 CA072309NIGMS NIH HHS GM57966NIGMS NIH HHS R01 GM057966
6 · The paper itself

Abstract

Covalent attachment of palmitate to proteins is a post-translational modification that exerts diverse effects on protein localization and function. The three key technical approaches required for an investigator to determine the role of palmitoylation of your favorite palmitoylated protein (YFPP) are methods to: (1) detect YFPP palmitoylation; (2) alter or inhibit palmitoylation of YFPP; (3) determine the functional significance of altered YFPP palmitoylation. Here, I describe experimental methods to address these three issues. Both radioactive (radiolabeling with [(3)H]palmitate or (125)I-IC16 palmitate) and non-radioactive (chemical labeling and mass spectrometry) methods to detect palmitoylated proteins are presented. Next, techniques to inhibit protein palmitoylation are described. These include site specific mutagenesis, and treatment of cells with inhibitors of protein palmitoylation, including 2-bromopalmitate, cerulenin, and tunicamycin. Alternative methods to replace palmitate with other fatty acids are also presented. Finally, general approaches to determining the effect of altered palmitoylation status on YFPP association with membranes and lipid rafts, as well as signal transduction, are described.

Indexed as

AcylationAcyltransferasesAnimalsHumansMutagenesis, Site-DirectedPalmitic AcidProteinsAcyltransferasesPalmitic AcidProteins

Identifiers

PMID17012032
PMCPMC1712572
OpenAlexW2068034774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.